Apertura Gene Therapy
Private
Services: Develops AAV gene therapy vectors for neurological disease delivery using proprietary Flash capsid technology
Company Info
Upcoming Milestones & Key Dates
Q3/Q4 2026
Earnings
Q2 2026 corporate update
Recent News
No recent news updates available for this company.
Leadership Team
Careers & Job Openings